Bosutinib Tablets 400 mg was filed under the first-to-file category, making it eligible for 180 days of generic drug exclusivity in the US for this dosage strength.
Bosutinib Tablets 400 mg was filed under the first-to-file category, making it eligible for 180 days of generic drug exclusivity in the US for this dosage strength.